文献速递颈动脉与弓上血管

经颈动脉血运重建联合动态血流逆转对比经股动脉颈动脉支架置入与颈动脉内膜剥脱术的系统综述与荟萃分析

A Systematic Review and Meta-Analysis of Transcarotid Artery Revascularization with Dynamic Flow Reversal Versus Transfemoral Carotid Artery Stenting and Carotid Endarterectomy.
PubMed 文献 · Ann Vasc Surg · 2020-06-04

该系统综述与荟萃分析纳入9项非随机研究、共4012例接受经颈动脉血运重建(TCAR)联合动态血流逆转的患者,估计其30天卒中/死亡风险为1.89%(95%CI:1.50,2.37),并与经股动脉颈动脉支架置入(TFCAS)及颈动脉内膜剥脱术(CEA)比较。TCAR的30天卒中/死亡风险低于TFCAS,与CEA相近但颅神经损伤风险更低;作者认为仍需更大样本的前瞻性研究以控制混杂因素。

要点

  • TCAR联合动态血流逆转的30天卒中/死亡风险为1.89%,处于较低水平。
  • 与TFCAS相比,TCAR的卒中/死亡风险更低;与CEA相比卒中/死亡风险相近。
  • TCAR的颅神经损伤风险低于CEA,但证据来自非随机研究。

核心结论

  • 在接受TCAR联合动态血流逆转治疗颈动脉狭窄的患者中,30天卒中或死亡风险较低。
  • TCAR的围手术期卒中/死亡率与CEA相似,而颅神经损伤风险低于CEA。
  • 仍需更大规模的前瞻性研究以控制混杂因素并提供更高证据确定性。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Cochrane、Embase和Scopus数据库中接受TCAR治疗的患者研究。
  • 纳入9项非随机研究,共评估4012例接受TCAR的患者。
  • 采用logistic-normal随机效应模型(logit转换)估计TCAR后的合并事件率,采用固定效应模型计算TCAR对比TFCAS和CEA的Mantel-Haenszel合并OR。
  • 采用似然比检验的卡方统计量比较随机效应与固定效应模型以量化研究间异质性。

主要发现

  • TCAR后总体30天风险:卒中/死亡1.89%(95%CI:1.50,2.37);卒中1.34%(95%CI:1.02,1.75);死亡0.76%(95%CI:0.56,1.08);心肌梗死0.60%(95%CI:0.23,1.59);卒中/死亡/心肌梗死2.20%(95%CI:1.31,3.69);颅神经损伤0.31%(95%CI:0.12,0.83)。
  • TCAR的失败率为1.27%(95%CI:0.32,4.92)。
  • 两项非随机研究提示TCAR较TFCAS的卒中与死亡风险更低(1.33% vs. 2.55%,OR:0.52,95%CI:0.36,0.74;0.76% vs. 1.46%,OR:0.52,95%CI:0.32,0.84)。
  • 四项非随机研究提示TCAR较CEA的颅神经损伤风险更低(0.54%和1.84%,OR:0.52,95%CI:0.36,0.74),但30天卒中、卒中/死亡或卒中/死亡/心肌梗死风险无统计学显著差异。

关键数值与推荐

  • TCAR后30天卒中/死亡合并风险1.89%(95%CI:1.50,2.37),卒中1.34%(95%CI:1.02,1.75),死亡0.76%(95%CI:0.56,1.08)。
  • TCAR后30天心肌梗死0.60%(95%CI:0.23,1.59),卒中/死亡/心肌梗死2.20%(95%CI:1.31,3.69),颅神经损伤0.31%(95%CI:0.12,0.83),TCAR失败率1.27%(95%CI:0.32,4.92)。
  • TCAR对比TFCAS的卒中/死亡OR为0.52(95%CI:0.36,0.74;95%CI:0.32,0.84,分别对应两项研究)。
  • TCAR对比CEA的颅神经损伤OR为0.52(95%CI:0.36,0.74),而30天卒中、卒中/死亡、卒中/死亡/心肌梗死风险无统计学显著差异。

临床怎么用

  • 对于颈动脉狭窄患者,TCAR联合动态血流逆转可作为围手术期卒中/死亡风险较低的颈动脉血运重建选择。
  • 在高手术风险患者中,TCAR在卒中/死亡方面可能优于TFCAS,且颅神经损伤风险低于CEA。
  • 应用上述结果时需结合研究均为非随机设计这一证据局限,个体化决策。

局限性

  • 纳入研究均为非随机研究,存在混杂因素,证据确定性有限。
  • 比较TCAR与TFCAS、CEA的研究数量较少(分别为2项和4项),合并估计需谨慎解读。
  • 作者指出仍需更大规模的前瞻性研究以控制混杂因素并提供更高证据确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transfemoral carotid artery stenting (TFCAS) was introduced as a less invasive option for carotid revascularization in patients at high risk for complications from carotid endarterectomy (CEA). The increased perioperative stroke and death risk of TFCAS has however prevented TFCAS from widespread acceptance as an alternative to CEA in high-risk patients. Recent research suggests that transcarotid artery revascularization (TCAR) may be associated with a low stroke and death risk and potentially meet the needs of patients at high surgical risk. We aimed to estimate the 30-day risk of stroke or death of TCAR and compare it to TFCAS and CEA. METHODS: We searched PubMed, Cochrane, Embase, and Scopus for studies of patients treated with TCAR. Meta-analysis was conducted when appropriate. A logistic-normal random-effects model with logit transformation was used to estimate the pooled event rates after TCAR. Pooled Mantel-Haenszel odds ratios (ORs) of events comparing TCAR to TFCAS and CEA were calculated using a fixed-effects model. Heterogeneity among studies was quantified with the chi-squared statistic of the likelihood ratio (LR) test that compares the random-effects and fixed-effects models. RESULTS: Nine nonrandomized studies evaluating 4012 patients who underwent TCAR were included. The overall 30-day risks after TCAR were stroke/death, 1.89% (95% confidence interval [CI]: 1.50, 2.37); stroke, 1.34% (95% CI: 1.02,1.75); death, 0.76% (95% CI: 0.56, 1.08); myocardial infarction (MI), 0.60% (95% CI: 0.23, 1.59); stroke/death/MI, 2.20% (95% CI: 1.31, 3.69); cranial nerve injury (CNI), 0.31% (95% CI: 0.12, 0.83). The failure rate of TCAR was 1.27% (95% CI: 0.32, 4.92). Two nonrandomized studies suggested that TCAR was associated with lower risk of stroke and death as compared with TFCAS (1.33% vs. 2.55%, OR: 0.52, 95% CI: 0.36, 0.74 and 0.76% vs. 1.46%, OR: 0.52, 95% CI: 0.32, 0.84, respectively). Four nonrandomized studies suggested that TCAR was associated with a lower risk of CNI (0.54% and 1.84%, OR: 0.52, 95% CI: 0.36, 0.74) than CEA, but no statistically significant difference in the 30-day risk of stroke, stroke/death, or stroke/death/MI. CONCLUSIONS: Among patients undergoing TCAR with dynamic flow reversal for carotid stenosis the 30-day risk of stroke or death was low. The perioperative stroke/death rate of TCAR was similar to that of CEA while CNI risk was lower. Larger prospective studies are needed to account for confounding factors and provide higher certainty.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Naazie IN, Cui CL, Osaghae I, et al. A Systematic Review and Meta-Analysis of Transcarotid Artery Revascularization with Dynamic Flow Reversal Versus Transfemoral Carotid Artery Stenting and Carotid Endarterectomy. Ann Vasc Surg. 2020. PMID: 32505684. doi:10.1016/j.avsg.2020.05.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。